MTOR and cardiovascular disorder: Inhibition of mTOR activity (through, for example, AMPK activation) is thought to be associated with increased lifespan in lower organisms, like yeast, and with delayed aging and protection against age-dependent diseases (such as cardiovascular disease, neurodegenerative diseases) in more complex organisms [38,46,47].